Hypercholesterolemia Clinical Trials

A listing of Hypercholesterolemia medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 161 clinical trials
Study to Assess the Real World Effectiveness of Inclisiran in Chinese Adult Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia

This is a multi-center, prospective, comparative and non-interventional cohort study involving two cohorts, one cohort (Inclisiran Cohort) of patients treated with inclisiran in certain special territories in China (eg. Bo'ao Pilot Zone) and the other cohort (SoC Historical Cohort) of patients treated with standard of care (SoC) in routine clinical …

  • 0 views
  • 27 May, 2022
  • 2 locations
Diet Quality and Coronary Artery Calcification in Adults With Heterozygous Familial Hypercholesterolemia (FH-CAC)

The overarching objective is to evaluate the relationship between diet and coronary artery calcification in patients with heterozygous familial hypercholesterolemia (HeFH). We will recruit

Accepts healthy volunteers
  • 0 views
  • 15 May, 2022
  • 1 location
Non-interventional Study on the Monthly Administration of 300 mg AliRocumab (PRALUENT®) With the 2 ml SYDNEY Auto-injector (MARS)

Primary objectives: To assess the effectiveness of the PRALUENT® 2 ml SYDNEY auto-injector as measured by the lipid-lowering effect of alirocumab after approx. 12 weeks treatment To assess the treatment satisfaction, as well as patient adherence and persistence after approximately 12 weeks of treatment with the PRALUENT® 2 ml SYDNEY …

  • 0 views
  • 14 Jun, 2022
  • 1 location
Non-interventional Study on the Monthly Administration of 300 mg AliRocumab (PRALUENT®) With the 2 ml SYDNEY Auto-injector (MARS)

Primary objectives: To assess the effectiveness of the PRALUENT® 2 ml SYDNEY auto-injector as measured by the lipid-lowering effect of alirocumab after approx. 12 weeks treatment To assess the treatment satisfaction, as well as patient adherence and persistence after approximately 12 weeks of treatment with the PRALUENT® 2 ml SYDNEY …

  • 0 views
  • 10 Jun, 2022
  • 1 location
Plasma Hydrogen Sulfide as a Biomarker for Alzheimer's Disease and Related Dementias

Hydrogen sulfide is a signaling molecule that is important for vascular health. Because vascular factors such as hypertension and high cholesterol are risk factors for Alzheimer's disease and

depression
dementia
cognitive decline
alzheimer's disease
Accepts healthy volunteers
  • 0 views
  • 25 Jan, 2022
  • 1 location
Genetesis Accelerated Registry

are not limited to high blood pressure, high cholesterol, family history of heart disease, and diabetes. The purpose of the Genetesis Accelerated Registry (GEAR) study is to understand the potential

diabetes
  • 5 views
  • 28 Sep, 2021
  • 1 location
Long-term Characterization of Lipoprotein Apheresis Technologies for Individual Device Adaption (LOLIDA) (LOLIDA)

patients with severe homo- or heterozygous familial hypercholesterolemia (FH) or otherwise highly elevated LDL-cholesterol were subjected to lipoprotein apheresis, currently the major indication for

hypercholesterolemia
atherosclerosis
dyslipidemia
cholesterol measurement
  • 0 views
  • 21 Mar, 2022
Atherosclerosis in Chemotherapy-related Cardiotoxicity (ANTEC)

of hypercholesterolaemia and coronary artery disease in cancer patients, is one of the risk factors for cardiotoxicity. In recent years, a protective effect of statin treatment on the development of

cancer
heart failure
myocardial infarction
hmg-coa reductase inhibitor
diabetes
  • 0 views
  • 10 Mar, 2022
  • 1 location
Embryo Health Study

This study intends to determine the patients' perception and motivation to obtain additional information on their preimplantation embryos' risks of polygenic disorders. Patients undergoing IVF and genetic testing on their embryos for aneuploidies will be given the option to obtain information of their embryos' polygenic disease risk after receiving genetic …

  • 320 views
  • 17 Feb, 2021
  • 1 location
Metabolic Determinants of the Progression of Aortic Stenosis

Calcific aortic stenosis (AS) has become the most common cardiac disease after coronary artery disease and hypertension. Unfortunately no medical therapies have been proven to decrease either the progression of valve stenosis or the resulting adverse effects on myocardial remodeling and function. In light of the studies performed in PROGRESSA, …

coronary artery disease
ct scan
medical therapy
myocardial fibrosis
stenosis
  • 0 views
  • 27 Sep, 2021
  • 1 location